Crescentis reports Rs 7.8185 crore profit in June quarter

Crescentis reported unaudited net profit after tax and exceptional items of Rs 7.8185 crore for the quarter ended June 30, 2026, compared with Rs 3.3544 crore a year earlier, after audited losses in fiscal 2026 and fiscal 2025. Its rights-offer document uses the June-quarter financial and per-share data in its rationale for the Rs 78 issue price.

How did Crescentis move from annual losses to June profit?

Crescentis moved from audited losses of Rs 2.5263 crore in fiscal 2026 and Rs 5.4224 crore in fiscal 2025 to a June 2026 quarterly profit of Rs 7.8185 crore. Total revenue from operations was Rs 10.9434 crore in the June 2026 quarter, compared with Rs 4.9510 crore in the comparable June 2025 quarter. Profit before tax and exceptional items rose to Rs 9.6222 crore from Rs 4.1142 crore over the same quarterly periods.

The filing provides reported financial figures but does not attribute the change from two annual losses to the June-quarter profit to a specified transaction, investment gain, lending-income line or operating segment. Fiscal 2026 revenue was Rs 1.4838 crore, compared with negative Rs 3.0248 crore in fiscal 2025, while the annual net loss narrowed by Rs 2.8961 crore year on year. The June 2026 outcome was therefore different from both preceding audited full-year results.

What changed in Crescentis earnings per share and net worth?

Crescentis reported basic and diluted earnings per share, or EPS, of Rs 4.60 for the quarter ended June 30, 2026, compared with Rs 2.77 for the quarter ended June 30, 2025. Both measures were negative Rs 1.57 for fiscal 2026 and negative Rs 4.48 for fiscal 2025. The filing says prior-period EPS was recomputed for the July 15, 2025 rights issue and restated for its bonus element under Indian Accounting Standard 33.

Net worth stood at Rs 83.9196 crore on June 30, 2026, compared with Rs 33.0333 crore a year earlier and Rs 76.0432 crore at March 31, 2026. Equity share capital was Rs 17.0135 crore at June 30, 2026, versus Rs 10.0080 crore a year earlier, while reserves and surplus excluding statutory reserve rose to Rs 59.1311 crore from Rs 16.1431 crore. Net asset value, or NAV, per share was Rs 49.33, compared with Rs 33.01 a year earlier and Rs 44.70 at the end of fiscal 2026.

Return on net worth was 39.10% for the June 2026 quarter, compared with 42.73% for June 2025, with the filing stating that both quarterly ratios were annualised. For the full years, return on net worth was negative 4.77% in fiscal 2026 and negative 16.63% in fiscal 2025. Crescentis defines the ratio as profit or loss attributable to owners divided by average net worth.

Why is Crescentis offering rights shares at Rs 78?

Crescentis set the rights-issue price at Rs 78 per equity share, including a premium of Rs 68 over the Rs 10 face value, after evaluating historical market performance, trading liquidity and industry benchmarks. The company says the price represented a 22.77% discount to the BSE closing market price one trading day before the rights-price announcement. It also represented a 24.72% discount to the preceding 10-trading-day volume-weighted average price, or VWAP.

The filing lists an ex-rights price of Rs 94.34 per equity share under Regulation 10(4)(b) of the Securities and Exchange Board of India Takeover Regulations. It describes the Rs 78 issue price as 7.8 times the face value of an equity share. These are Crescentis’s disclosed pricing reference points, and the document does not provide an independent valuation or a forecast of the post-issue market price.

Crescentis included June 2026 EPS of Rs 4.60 and NAV per share of Rs 49.33 among the quantitative factors for the issue price. The corresponding June 2025 figures were Rs 2.77 and Rs 33.01. Fiscal 2026 EPS was negative Rs 1.57 despite NAV of Rs 44.70 per share, meaning the pricing discussion presents current-quarter and full-year measures rather than only one reporting period.

What business model and rights-issue terms did Crescentis disclose?

Crescentis describes a dual-engine model comprising listed equity investments and a growing lending portfolio. It says lending operations commenced in fiscal 2026 and identifies micro, small and medium enterprises, renewable-energy financing and healthcare-ecosystem players as target lending segments. The stated lending approach emphasises secured exposures, underwriting and portfolio monitoring, while the filing does not disclose June 2026 segment revenue, loan-book size or credit-loss data.

On October 29, 2026, Crescentis’s fund-raising committee resolved to offer three rights equity shares for every five shares held by eligible shareholders at Rs 78 each, aggregating to Rs 79.6234 crore. The board initially considered raising up to Rs 80 crore on May 29, 2026, then authorised the issue again on September 30, 2026. The stated issue size is Rs 37.66 lakh below the amount initially considered by the board.

BSE granted in-principle approval for listing the rights shares in a letter dated October 23, 2026, according to the filing. Crescentis said it would apply for trading approval for rights entitlements and later seek final listing and trading approval for allotted rights shares. The document states that there is no assurance of active or sustained trading in the rights shares after listing.

Conclusion

Crescentis’s June 2026 quarter reported Rs 7.8185 crore in profit after two audited loss-making years, while revenue from operations reached Rs 10.9434 crore and net worth reached Rs 83.9196 crore. The rights-price rationale combines this quarterly improvement with per-share metrics, historical market references and a disclosed Rs 94.34 ex-rights price, rather than identifying a single valuation measure.

The next disclosed developments are the Rs 79.6234 crore rights issue at Rs 78 per share, BSE trading approval for rights entitlements and final listing and trading approval for allotted shares. Later financial disclosures will show whether the June 2026 result continues, particularly because the filing does not separate reported revenue or profit between listed equity investments and lending activities.